236 related articles for article (PubMed ID: 36789030)
1. Effect of Methylprednisolone on Mortality and Clinical Courses in Patients with Severe COVID-19: A Propensity Score Matching Analysis.
Li X; Yuan X; Xu Z; Shi L; Huang L; Lu X; Fu J
Infect Dis Immun; 2023 Jan; 3(1):20-28. PubMed ID: 36789030
[TBL] [Abstract][Full Text] [Related]
2. Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19.
Li X; Yuan X; Xu Z; Huang L; Shi L; Lu X; Wang FS; Fu J
Infect Med (Beijing); 2022 Dec; 1(4):236-244. PubMed ID: 38013911
[TBL] [Abstract][Full Text] [Related]
3. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
Saeed MAM; Mohamed AH; Owaynat AH
Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study.
Aljuhani O; Korayem GB; Altebainawi AF; AlMohammady D; Alfahed A; Altebainawi EF; Aldhaeefi M; Badreldin HA; Vishwakarma R; Almutairi FE; Alenazi AA; Alsulaiman T; Alqahtani RA; Al Dhahri F; Aldardeer N; Alenazi AO; Al Harbi S; Kensara R; Alalawi M; Al Sulaiman K
BMC Infect Dis; 2024 Feb; 24(1):189. PubMed ID: 38350878
[TBL] [Abstract][Full Text] [Related]
5. Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China.
Lin L; Xue D; Chen JH; Wei QY; Huang ZH
World J Clin Cases; 2022 Jan; 10(2):426-436. PubMed ID: 35097067
[TBL] [Abstract][Full Text] [Related]
6. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study.
Liu J; Zhang S; Wu Z; Shang Y; Dong X; Li G; Zhang L; Chen Y; Ye X; Du H; Liu Y; Wang T; Huang S; Chen L; Wen Z; Qu J; Chen D
Ann Intensive Care; 2020 Jul; 10(1):99. PubMed ID: 32737627
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics, Outcomes, and Risk Factors of Disease Severity in Patients With COVID-19 and With a History of Cerebrovascular Disease in Wuhan, China: A Retrospective Study.
Li M; He Z; Yang J; Guo Q; Weng H; Luo J; Gong B; Cui W; Ding B; Guo J
Front Neurol; 2021; 12():706478. PubMed ID: 35087460
[No Abstract] [Full Text] [Related]
9. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
[TBL] [Abstract][Full Text] [Related]
10. Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load.
Zhao H; Tu H; Yu X; Su J; Zhang X; Xu K; Shi Y; Qiu Y; Sheng J
Infect Drug Resist; 2022; 15():1971-1979. PubMed ID: 35480060
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
[TBL] [Abstract][Full Text] [Related]
12. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis.
Liu K; Yang X; Feng C; Chen M; Zhang C; Wang Y
J Med Virol; 2022 Apr; 94(4):1402-1411. PubMed ID: 34766661
[TBL] [Abstract][Full Text] [Related]
14. Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases.
Zhu HM; Li Y; Li BY; Yang S; Peng D; Yang X; Sun XL; Zhang M
World J Clin Cases; 2020 Dec; 8(23):5952-5961. PubMed ID: 33344594
[TBL] [Abstract][Full Text] [Related]
15. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
16. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
[TBL] [Abstract][Full Text] [Related]
17. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
19. The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.
You X; Wu CH; Fu YN; He Z; Huang PF; Chen GP; Lin CH; Ming WK; Lin RF
PLoS One; 2020; 15(12):e0244128. PubMed ID: 33382734
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
